Join FDA on Monday, Dec. 11 for the ASH - FDA Joint Symposium I: Targeted, Gene and Cellular Therapy - Recent Approvals in Non-Malignant Hematology, 10:30 am -12 pm, SDCC, Room 7. #ASH23

Join FDA hematologists at the ASH -FDA Joint Symposium II: Striking a Balance - Benefit-Risk in Drug Approvals, Monday, Dec. 11, 2:45-4:45 pm, Marriott Marquis, Marriott Grand Ballroom – Salons 5-6. #ASH23 hematology.org/meetings/annua…

All set for the #ASH23 ⁦FDA Oncology⁩ session on benefit risk in new drug approvals. Come join us in Marriott Marquis Grand Ballroom 5-6! ⁦Cara Rabik, MD, PhD⁩

FDA approvals in 2023: biomarker-positive subsets, equipoise and verification of benefit - via NatureRevClinOncol by Kelly Norsworthy, MD Rosa Lee-Alonzo & Rick Pazdur nature.com/articles/s4157… #OCEPublications

Highly recommended to apply! A great chance to meet FDA reviewers ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology ASH FDA Oncology Jennifer Gao Kelly Norsworthy Kelly Norsworthy, MD Greg Talal Hilal 🩺 hematology.org/advocacy/get-i…

FDA's Oncology Center of Excellence has a new project launching soon... and you are invited to take part! Check back on here on May 5, Cinco de Mayo, to find out. Kelly Norsworthy, MD Jennifer Gao Donna Rivera Steven C. Cunningham

Prag-mat-ic: dealing with things sensibly and realistically in a way that is based on practical rather than theoretical considerations. (Oxford) FDA Oncology has a new project launching soon... Check back tomorrow! Kelly Norsworthy, MD Jennifer Gao Donna Rivera Steven C. Cunningham

Please consider posting your ideas for pragmatic clinical trials to this FDA Oncology crowdsourcing initiative #OCEProject5in5 starting today on 5/5 (no coincidence)!! Rick Pazdur Jennifer Gao Donna Rivera Steven C. Cunningham

🎇 Sign up and submit ideas for pragmatic clinical trials! Project 5 in 5: Crowdsourcing 5 clinically relevant questions for 5 pragmatic clinical trials! 💡 What's your clinical trial idea? Submit ideas here ➡️ shareyourvoice.ideascalegov.com/c/ #OCEProject5in5

Complete Remission with Partial Hematological Recovery as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia - via Blood Journal. First author Robert Le, last author R. Angelo De Claro. sciencedirect.com/science/articl… #OCEPublications

✨ Please add your feedback on ideas for #PragmaticTrials in Oncology submitted to #OCEProject5in5. Pick your favorites, comment, & propose your own to help shape the future of oncology drug development! 💡 Click here ⤵️ shareyourvoice.ideascalegov.com/c/landing

What are pragmatic clinical trials? Clinical trials that streamline data collection and design by collecting only necessary information to answer the research question. A thread 🧵 1/5 #ProjectPragmatica #OCEProject5in5 #PragmaticTrials

FDA approves imetelstat for low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. fda.gov/drugs/resource… #OCENewsBurst

FDA Oncology Center's Project 5 in 5 crowdsourcing initiative seeks 5 clinically relevant questions for 5 pragmatic clinical trials, using FDA-approved therapies! 💡 Got ideas? Sign up and submit ideas here ⤵️ shareyourvoice.ideascalegov.com/c/ #OCEProject5in5 #PragmaticTrials #ASCO24

Closing July 5! FDA Oncology Center Project 5 in 5 crowdsourcing initiative is seeking 5 clinically relevant questions for 5 pragmatic clinical trials, using FDA-approved therapies! 💡 Submit ideas by July 5! ⤵️ shareyourvoice.ideascalegov.com/c/ #OCEProject5in5 #PragmaticTrials

Last chance to submit your #PragmaticTrials ideas to FDA Oncology! Or simply log in to the crowdsourcing platform to see ideas others have posed - comment, like, and pick your favorites!

An expert panel convened by FDA provides perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding - via Clinical Cancer Research. First author Jorge Cortes MD, last author Kelly Norsworthy, MD. aacrjournals.org/clincancerres/…

Reporting results of an expert panel on drug development for CML in pregnancy, coordinated with FDA Oncology Kelly Norsworthy, MD Georgia Cancer Center Clinical Cancer Research aacrjournals.org/clincancerres/…

Just published! With Kelly Norsworthy, MD and other FDA authors Ashley Woods, R. Angelo de Claro, Marc R. Theoret and E. Dianne Pulte. #OCEPublications

Hot off the press in ⁦The Oncologist⁩,our paper on treatment of #AML in the community setting, I had the privilege of collaborating with outstanding group of oncologists and our colleagues at the ⁦FDA Oncology⁩ ⁦Kelly Norsworthy, MD⁩ ⁦⁦⁦ academic.oup.com/oncolo/advance…